Bourla said the experts were helping Pfizer “make better and more sound decisions,” and the company could start a late-stage study of its drug, danuglipron, in the second half of this year ...

Bourla plans to donate his prize money to “projects aimed at preserving the memory of the victims of the Holocaust, with a particular emphasis on the tragedy suffered by the Greek Jewish ...